ESG10 April 2026 at 04:18 am
Zydus Lifesciences' ESG Rating Improves to 68 from 66 by Independent ESGRAIL Assessment
AI Summary
Zydus Lifesciences Ltd. has received an updated ESG (Environmental, Social, and Governance) rating of 68 from ESGRAIL, a SEBI-registered ESG Rating Provider. This marks an improvement from the previous year's rating of 66. The company clarified that it did not engage ESGRAIL for this assessment; rather, the report was independently prepared by ESGRAIL based on publicly available information. The report was received on April 9, 2026. This disclosure is made in compliance with Regulation 30 of the Listing Regulations and relevant SEBI Circulars, highlighting the company's commitment to transparency regarding its ESG performance.
Key Highlights
- Zydus Lifesciences' overall ESG rating improved to 68, up from 66 in the previous year, as assessed by ESGRAIL.
- The ESG assessment was conducted independently by ESGRAIL, a SEBI-registered provider, using only publicly available information, lending credibility to the rating.
- The company's improved ESG score could positively influence investor perception, particularly among those focused on sustainable and responsible investing.
- This disclosure ensures regulatory compliance under SEBI Listing Regulations, demonstrating transparency in reporting non-financial performance.
ZYDUSLIFEPharmaceuticals
Zydus Lifesciences LtdPrice Impact